A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD
Clinical trial NCT04821687 · COMPLETED
Trial details
- NCT number
- NCT04821687
- Sponsor
- SK Chemicals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-17
- Primary completion
- 2022-08-18
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.